Comparative Pharmacology
Head-to-head clinical analysis: DALMANE versus RESTORIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DALMANE versus RESTORIL.
DALMANE vs RESTORIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Binds to benzodiazepine site on GABA-A receptor, enhancing GABA inhibitory effects, leading to increased chloride ion influx, hyperpolarization, and sedation.
Temazepam is a benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA) at the GABA-A receptor, leading to increased chloride ion influx and hyperpolarization of the postsynaptic neuron, resulting in sedation and anxiolysis.
15-30 mg orally at bedtime; maximum 30 mg/day.
Oral: 15-30 mg once daily at bedtime, as needed for insomnia. Maximum dose: 30 mg/day.
None Documented
None Documented
Terminal elimination half-life is 47-100 hours (mean 75 h) in adults; prolonged in elderly (up to 160 h) and cirrhosis (up to 200 h).
Terminal elimination half-life is approximately 10-15 hours in healthy adults. Clinical context: Half-life may be prolonged in elderly patients and those with hepatic impairment; accumulation may occur with repeated dosing, leading to prolonged sedation.
Renal excretion of metabolites (~90%) and unchanged drug (<1%); fecal excretion (~1-2%).
Renal (approximately 80% as conjugated metabolites, less than 2% unchanged); fecal (approximately 20%).
Category C
Category C
Benzodiazepine Hypnotic
Benzodiazepine Hypnotic